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Vasculitides constitute a heterogeneous group of disorders affecting from large 
arteries to post-arteriolar capillaries. These disorders can affect all organs and are 
categorized on the basis of the affected artery diameter and the presence or absence 
of antibodies to neutrophil cytoplasmic antigens (ANCA). ANCA-positive vasculiti-
des involve small to medium size arteries of many organs, primarily of the upper and 
lower respiratory system, the kidneys and the peripheral nervous system. Microscopic 
polyangiitis (MPA), Wegener granulomatosis (WG) and Churg-Strauss syndrome (CS) 
are forms of these vasculitides. Coronary arteries have been previously shown to be 
occasionally affected during the course of these diseases; however, this has never 
been formally assessed.
To evaluate non-invasively the coronary arteries of patients with ANCA-positive 
vasculitides, magnetic resonance angiography (MRA) was perfomed and the viability 
was studied using contrast enhanced MRI (ceMRI). Twelve patients with MPA, 13 
with WG, 5 with CS and 2 with polyarteritis nodosa (PAN), all without any cardiac 
symptoms were included in the study and compared with 13 age- and sex-matched 
healthy controls and with a disease control group of 13 patients with rheumatoid ar-
thritis (RA). The maximal diameter of the proximal 1/3 of each coronary vessel was 
recorded. MRA was performed using a 1.5 T system. Data acquisition was performed 
with ECG gating in mid-diastole and with the patient free breathing. ceMRI images 
were acquired 15 minutes after the IV injection of 0.15 mmol/kg gadolinium-diethyl-
ene triamine pentaacetic acid (Gd-DTPA) using an inversion recovery gradient echo 
pulse sequence.
As shown in the table, the diameter of all coronary arteries tested were found sig-
nificantly increased in patients with MPA, PAN and WG (p<0.001 for LAD and RCA, 
p<0.01 for LCx) compared to controls, but not in those with CS. Criteria for ectasia 
were fullfiled by MPA and PAN patients, but not WG. The comparison of coronary 
vessel diameters revealed increased coronary artery diameter in the MPA+PAN patient 
group compared to that of WG (p<0.05 for LAD and LCx, p<0.01 for RCA). Coro-
nary vessel diameters were increased in MPA+PAN group compared to RA (p<0.01 
for LAD and RCA and p<0.05 for LCx), but there was no difference between WG or 
CS and RA. Evidence of myocardial scar in Gd-DTPA images was documented in 1 
patient with MPA and in 1 patient with CS.
In conclusion, coronary artery ectasia appears a common finding in asymptomatic 
vasculitis patients, while scar is rare. Magnetic resonance evaluation is feasible in these 
forms of vasculitis and may prove of value for treatment guidance.
CARDIOLOGY UPDATE 2006
Professor & Director, Department 
of Pathophysiology, School of 
Medicine, National University of 
Athens, Athens, Greece, e-mail: 
hmoutsop@med.uoa.gr
HOSPITAL CHRONICLES 2006, SUPPLEMENT: 97–98
Address for correspondence:





National University of Athens
75 Mikras Asias Street
115 27 Athens, Greece
Tel.: + 30 210 746 2512 - 14
Fax.: + 30 210 746 2664
e-mail.: hmoutsop@med.uoa.gr
98
HOSPITAL CHRONICLES, SUPPLEMENT 2006
R E F E R E N C E
 1. Manoussakis M, et al. Coronary artery and viability evaluation 
in ANCA-positive vasculitides using magnetic resonance imag-
ing. Ann Rheum Dis 2006; in press.
TABLE. Coronary vessel diameters (mean ± SD) in patients and controls
Coronary vessel MPA+PAN WG CS RA Healthy controls
LAD (mm) 4.58±1.27 3.57±0.69 2.66±0.51 3.06±0.60 3.05±0.15
RCA (mm) 4.68±1.00 3.55±0.92 2.68±0.77 3.27±0.81 3.17±0.20
LCx (mm) 4.01±1.16 3.16±0.45 2.48±0.73 3.20±0.56 3.08±0.19
CS= Churg-Strauss syndrome; LAD= left anterior descending (coronary artery); LCx= left circumflex; MPA= microscopic polyangiitis; PAN= 
polyarteritis nodosa; RA= rheumatoid arthritis; RCA= right coronary artery; WG= Wegener’s granulomatosis
